Deutsche Bank’s Elicio Therapeutics ELTX Stock Holding History
Bought
Maintained
Sold
Other funds holding ELTX
KCM
IC
Deutsche Bank's ELTX Position: Q2 2026 in Review
Deutsche Bank opened a new position in Elicio Therapeutics (ELTX) in Q2 2026: 12,652 shares worth $49.5K. The stake represents ﹤0.01% of the portfolio and ranks #3568 among its holdings. This is a return to the name: Deutsche Bank previously reported a position in ELTX as recently as Q1 2022.
Deutsche Bank first reported a position in ELTX in Q1 2021 and has held it in 6 quarters since. The position peaked at $138K in Q3 2021. 48 funds tracked by Wall St. Rank hold ELTX as of Q2 2026.
- Deutsche Bank held 12,652 shares of Elicio Therapeutics worth $49.5K as of Q2 2026.
- Elicio Therapeutics was a new Deutsche Bank position in Q2 2026.
- Elicio Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #3568 holding.
- Deutsche Bank first reported a position in Elicio Therapeutics in Q1 2021 and has held it in 6 quarters since.
- Deutsche Bank's Elicio Therapeutics position peaked at $138K in Q3 2021.
- 48 funds tracked by Wall St. Rank held Elicio Therapeutics as of Q2 2026.
Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.